Literature DB >> 3354416

Cardiac failure and sudden death in the Framingham Study.

W B Kannel1, J F Plehn, L A Cupples.   

Abstract

Mortality is examined in patients with cardiac failure in the Framingham study of 5209 subjects. During 30 years of follow-up, the incidence of cardiac failure doubled with each decade of age with a male predominance produced by higher rates of coronary heart disease. Most cardiac failure was associated with hypertension or coronary heart disease. Among 232 men and 229 women in whom cardiac failure developed, sudden death occurred at nine times the general age-adjusted population rate. Cardiac failure alone increased the risk of sudden death fivefold. In those who also had coronary heart disease there was a further doubling of risk. The major predisposing factors for cardiac failure included hypertension, obesity, glucose intolerance, heavy smoking, cardiac enlargement, ECG abnormality, and atrial fibrillation. These were also risk factors for sudden death. These shared modifiable risk factors and cardiac impairments did not entirely account for the markedly increased risk of sudden death in cardiac failure. This suggest that either the damaged myocardium or treatment needed to control the cardiac failure may be at fault.

Entities:  

Mesh:

Year:  1988        PMID: 3354416     DOI: 10.1016/0002-8703(88)90891-5

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  54 in total

Review 1.  Cardiovascular consequences of obese and nonobese obstructive sleep apnea.

Authors:  Kannan Ramar; Sean M Caples
Journal:  Med Clin North Am       Date:  2010-05       Impact factor: 5.456

2.  Evaluation of Changes in Ventricular Repolarization Parameters in Morbidly Obese Patients Undergoing Bariatric Surgery.

Authors:  Ersin Ibisoglu; Deniz Dilan Naki Tekin; Filiz Kızılırmak; Saime Turgut Güneş; Bedrettin Boyraz; Yaşar Özdenkaya; Sinem Çakal; Beytullah Çakal; Ümeyir Savur; Aslan Erdoğan; Fatih Erkam Olgun; H Murat Güneş
Journal:  Obes Surg       Date:  2021-04-15       Impact factor: 4.129

3.  Chronic heart failure and the substrate for atrial fibrillation.

Authors:  Arun Sridhar; Yoshinori Nishijima; Dmitry Terentyev; Mahmood Khan; Radmila Terentyeva; Robert L Hamlin; Tomohiro Nakayama; Sandor Gyorke; Arturo J Cardounel; Cynthia A Carnes
Journal:  Cardiovasc Res       Date:  2009-06-30       Impact factor: 10.787

4.  Adjusting and comparing survival curves by means of an additive risk model.

Authors:  P H Zahl; O O Aalen
Journal:  Lifetime Data Anal       Date:  1998       Impact factor: 1.588

Review 5.  Drug treatment of heart failure.

Authors:  P A Poole-Wilson
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 6.  Effects of Bariatric Surgery on Heart Rhythm Disorders: a Systematic Review and Meta-Analysis.

Authors:  Elijah E Sanches; Besir Topal; Frank W de Jongh; Eylem Cagiltay; Alper Celik; Magnus Sundbom; Rui Ribeiro; Chetan Parmar; Surendra Ugale; Kamal Mahawar; Marc P Buise; Lukas R Dekker; Dharmanand Ramnarain; Sjaak Pouwels
Journal:  Obes Surg       Date:  2021-03-13       Impact factor: 4.129

Review 7.  Early intervention in heart failure.

Authors:  M A Creager
Journal:  Drugs       Date:  1990       Impact factor: 9.546

8.  Interleukin-17 is Not Associated with Risk of Premature Coronary Artery Disease in Iranian Turks.

Authors:  Kamal Khadem-Vatani; Morteza Bagheri; Isa Abdi Rad; Salar Mahmoudi-Nejad; Mahsa Hassan-Nejad
Journal:  Maedica (Bucur)       Date:  2020-06

Review 9.  Prediction of heart rate variability on cardiac sudden death in heart failure patients: a systematic review.

Authors:  Lang Wu; Zhouqin Jiang; Changwei Li; Maoqin Shu
Journal:  Int J Cardiol       Date:  2014-04-26       Impact factor: 4.164

10.  Abnormalities of the repolarization characteristics of patients with heart failure progress with symptom severity.

Authors:  Christopher C E Lang; James M M Neilson; Andrew D Flapan
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-07       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.